A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HLA / human leukocyte antigen

[Related PubMed/MEDLINE]
Total Number of Papers: 12526
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HLA  (>> Co-occurring Abbreviation)
Long Form:   human leukocyte antigen
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 HN, HPIV3
2022 allo-HCT, MMUD, MSD, MUD, UCB
2022 AA, ATG, HSCT, PBSC, PTCy
2022 iSNVs
2022 AFT, DCGF, EMM, TcEMM, WGCNA
2022 ICIs, irAEs
2022 APC, HNSCC, MHCII, PDAC, TCRs
2022 anti-TPO antibodies, CTLA, GD, HT, TPO, TRAb, TRAb, TSGT
2022 IL, NK, TCR-T
10  2022 HIV
11  2022 COVID-19, SARS-CoV-2
12  2022 allo-SCT, FDTCC, PTCy, RIC
13  2022 Abs, DN, GSTT1
14  2022 CIN, LOH, LUSC, NSCLC, PD-L1, TMB, TME
15  2022 ETUCAR-T, NK, TCR, UCAR-T
16  2022 HIV-1, IMC, LucR, VIA
17  2022 NGM
18  2022 SARS-CoV-2
19  2022 iPSC, MHC
20  2022 EVTs, GDM, IRS
21  2022 IMIDs, RA, SLE, SSc
22  2022 MHC, NGS
23  2022 SCDI
24  2022 haplo-SCT, QoL, SAA
25  2022 uORFs, uPeptides
26  2022 CHB, HIV, KIRs, NK
27  2022 LN, PCR-SSP, SLE
28  2022 AR, cPRA, MFI, RIS
29  2022 MFI, PRA
30  2022 MHC, non-V-SAT, SARS-CoV-2, SAT, V-SAT
31  2022 PBMNC
32  2022 CI, COVID-19, CT, OR, PCR
33  2022 axSpA, CRP, TNFi
34  2022 B-VSTs, GMP, HSCT, VSTS, VSTs
35  2022 HBV, HCV, PBMCs, uPA
36  2022 MD, RMSD, RMSF, WNV
37  2022 APS, HT
38  2022 IIM, MYOGEN, PM
39  2022 3pHLA-score improves structure-based peptide-HLA binding affinity prediction. ML, pHLA
40  2022 A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivo. CAR, CEA, LIR-1
41  2022 A Case of Methimazole-Induced Acute Pancreatitis With an HLA Allele Causing Antithyroid Drug-Induced Agranulocytosis. MIP, MMI, PTU
42  2022 A case of successful desensitization using therapeutic plasma exchange in high-risk HLA incompatible kidney transplantation. CKD, MFI, SAB
43  2022 A CD33 frameshift variant is associated with neuromyelitis optica spectrum disorders. AQP4-Ab, IL, NMOSD, WES
44  2022 A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant. HSCT
45  2022 A comprehensive human leukocyte antigen analysis of 36 782 cord blood units stored in the Australian Public Cord Blood Banking Network. CBBs, CBU
46  2022 A Computational Pipeline for Predicting Cancer Neoepitopes. MuPeXI
47  2022 A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South Africa. GWAS, RA, SEBSSAs
48  2022 A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies. AINS, GENERATE, GWAS, PRKCB
49  2022 A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design. HIV-1, MSM
50  2022 A national proficiency scheme for human leucocyte antigen typing by next-generation sequencing. HSCT, NGS, PT, SOT
51  2022 A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer. GC, GEO, MSI, NRG risk score, TMB
52  2022 A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources. ---
53  2022 A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer. CMap, DEG, GDSC, GEO, GEPIA, HPA, OC, TMB, TMBrisk, WGCNA
54  2022 A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice. BCG, CFUs, TB, Th1
55  2022 A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies. ---
56  2022 A short HLA-DRA isoform binds the HLA-DR2 heterodimer on the outer domain of the peptide-binding site. APCs, sHLA-DRA
57  2022 A short review on cervical cancer cell lines characterization and their corresponding human leukocyte antigen (HLA) type expression. ---
58  2022 A Single-Center Experience on HLA Typing with 11 Loci Next Generation Sequencing in Korean Patients with Hematologic Disease. NGS
59  2022 A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome. IFN
60  2022 A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity. IgG4-AID
61  2022 A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus. HBV
62  2022 ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation. cPRA
63  2022 Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report. AA, anti-GBM disease, IST, MP, PSL
64  2022 Acute Ischemic Stroke Due to Spontaneous Internal Carotid Artery Dissection in a Human Leukocyte Antigen (HLA) B27 Young Male. MRA, MRI, USG
65  2022 Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection. HBV, HCV, HDV, HIV, IFN
66  2022 Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors. ACT, TCR, TIL
67  2022 Advances in the Pathomechanisms of Delayed Drug Hypersensitivity. TCR
68  2022 Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantation. CBT
69  2022 Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation. AMR, DSAs, IgG, NK
70  2022 Allele and Haplotype Frequencies of HLA-A, -B, -C, and -DRB1 Genes in 3,750 Cord Blood Units From a Kinh Vietnamese Population. PCR-SSO
71  2022 Allele frequency and the associations of HLA-DRB1 and HLA-DQB1 polymorphisms with pemphigus subtypes and disease severity. HLA-DQB1, PF, PV
72  2022 Allelic imbalance of HLA-B expression in human lung cells infected with coronavirus and other respiratory viruses. AE
73  2022 Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro. ADA, NAb, OR
74  2022 Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure. GVHD, HCT, SCD
75  2022 Alloimmune Risk Stratification for Kidney Transplant Rejection. EMA
76  2022 Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant Couples. HIV, HIV
77  2022 Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions. PR
78  2022 An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19. COVID-19, DAT, Rh
79  2022 An autoencoder-based deep learning method for genotype imputation. AE, CR, DL, GWAS, IQS, LOS, SCDA, SEN
80  2022 An autologous humanized patient-derived xenograft (PDX) model for evaluation of nivolumab immunotherapy in renal cell cancer: a case report. HSPCs, mRCC, NK, NSG, PDX, RCC
81  2022 An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis. GWA, MRUC, non-MRUC, OR, UC
82  2022 An immunogenetic investigation of 30 autoimmune and autoinflammatory diseases and their links to psychiatric disorders in a nationwide sample. AIIDs
83  2022 Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer. HNC, HPV, Illumina, Inc, SNPs
84  2022 Analysis of KIR gene variants in The Cancer Genome Atlas and UK Biobank using KIRCLE. KIR, NK
85  2022 Analysis of temporal changes in HIV-1 CRF01_AE gag genetic variability and CD8 T-cell epitope evolution. CRF, CTL, HIV-1
86  2022 Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies. AECAs, AMBR, DSA
87  2022 Appearance of Anti-MDA5 Antibody-Positive Dermatomyositis After COVID-19 Vaccination. COVID-19, GAD, MDA5
88  2022 Approach to Highly Sensitized Kidney Transplant Candidates and a Positive Crossmatch. ---
89  2022 Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa. Bu, CY, GVHD, THIO
90  2022 Assessment of Human Leukocyte Antigen Differences between Smokers with Reinke's Edema and Those with Laryngeal Cancer. PCR-SSP, SCC
91  2022 Assessment of human leukocyte antigen matching algorithm PIRCHE-II on liver transplantation outcomes. PIRCHE-II
92  2022 Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant. ATG, HSCT, OR
93  2022 Association between germ-line HLA and immune-related adverse events. HED, ICIs, irAEs
94  2022 Association between HLA alleles and sub-phenotype of childhood steroid-sensitive nephrotic syndrome. SDNS/FRNS, SSNS, SSNSWR
95  2022 Association between human leukocyte antigen class II (HLA-DRB and -DQB) alleles and outcome of exposure to Mycobacterium tuberculosis: a cross-sectional study in Nairobi, Kenya. IGRA, LTBI, PTB, TB
96  2022 Association between Human Leukocyte Antigen Polymorphism and Human Papillomavirus Infection in Brazilian Women. HPV
97  2022 Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population. AGEP, cADRs, DRESS, SJS/TEN
98  2022 Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies. ---
99  2022 Association of end-stage renal disease with HLA phenotypes and panel reactive antibodies in patients awaiting renal transplantation in Hunan Province. ESRD, PRA
100  2022 Association of HLA Alleles with Antiepileptic Drug-Induced Mild Cutaneous Reactions: A Case-Control Study of a Northeast Han Chinese Population. AEDs, cADRs, CBZ, LEV, MPE, OXC, SBT